Navigation Links
Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
Date:7/1/2008

DURHAM, N.C., July 1 /PRNewswire/ -- Two years after Addrenex Pharmaceuticals set it sights on building a new class of drugs to regulate "adrenergic excess," the small Durham company has signed its second major deal with Sciele Pharma, this time to co-develop a new compound for hypertension and other potential indications.

Adrenalin is well known as the hormone that triggers the "fight or flight" reaction in response stress or danger. But Addrenex scientists recognized this hormone, and its counterpart in the brain, noradrenalin, as regulators of diverse physiologic functions -- from blood pressure to energy expenditure to thermostatic control.

"No other company is targeting adrenergic regulation as the root cause of conditions," said Moise Khayrallah, CEO of Addrenex. "We built our company to address a wide range of conditions whose symptoms are being partially managed by drugs currently on the market, but whose origins have never been specifically treated."

Last year the company efficiently advanced its first products, Clonicel(R) to treat attention deficit hyperactivity disorder and CloniBID to treat hypertension, into Phase 3 clinical trials. In July 2007, Addrenex licensed both products to Sciele Pharma for $6 million in upfront equity, $11 million in milestones, and future royalty payments on product sales.

One year later, the company has signed this second, larger deal, to include up to $27 million in development and regulatory milestones and future royalty payments on product sales. In addition, Sciele will pay all development costs.

"The partnership with Sciele is particularly rewarding because validates our work to date and confirms that our products may fill a critical gap in the treatment of debilitating conditions," said Khayrallah.

Addrenex began its foray into drug development by tweaking an existing drug, clonidine, to extend its benefits and reduce bothersome side effects. Company co-founder Joseph Ho
'/>"/>

SOURCE Addrenex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
2. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
3. Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
4. Alseres Pharmaceuticals, Inc. Raises $5 Million
5. Raptor Pharmaceuticals Closes $10 Million Private Placement
6. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
7. VIA Pharmaceuticals Set to Join Russell Microcap Index
8. Wyeth Pharmaceuticals Announces Organizational Change
9. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
10. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
11. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  Dr. Gerald ... nucleic acid research, recently launched a new blog in ... Zon ( zon.trilinkbiotech.com ), focuses on what,s trending in ... with industry thought leaders, discussions of research presented at ... Dr. Zon (PhD Princeton University 1971) ...
(Date:5/20/2013)... May 20, 2013 Pacific Biomarkers and Clinigene International ... developers of biosimilars at the 2013 AAPS/ National ... Diego Hotel and Marina , ... the opportunity to speak with company representatives at their ... Cross" on May 21 from 1-2 p.m. in the ...
(Date:5/20/2013)... May 20, 2013 With bed bugs' presence ... that although bed bugs need to be eliminated, one must ... compromise a person's health. And so to help bed bug ... get rid of bed bugs without using harmful ... bug spray it called Bed Bug Bully. , According to ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 ... regional private-public partnership focusing on commercializing market-relevant biohealth ... Central Maryland , today announced ... the first Entrepreneur-in-Residence (EIR) for BHI at the ... Lung and Blood Institute (NHLBI). Dr. Aiyar ...
Breaking Biology Technology:Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
... ST. LOUIS, June 2 SAFC Hitech(TM), a ... Group (Nasdaq: SIAL ),today announced the introduction ... cost-efficient migration path to controlled precursor delivery,for larger ... combined,with increased safety controls., The OM700 offers ...
... expertise, SAN DIEGO, June 2 Trius ... to its Board of Directors. Truex is,the founder, ... as President and CEO of Peninsula Pharmaceuticals where ... $21000000 from a key,strategic partner) and negotiated both ...
... Further ... Clinical Development of tgAAC94, BOSTON and SEATTLE, May 30 ... release earlier today, entitled,"Targeted Genetics Reports Additional Data From Inflammatory ... study of tgAAC94 in patients with inflammatory arthritis. Pervin,Anklesaria, Ph.D., ...
Cached Biology Technology:SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production 2SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production 3Trius Appoints Paul Truex to Board of Directors 2Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings 2Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings 3
(Date:5/16/2013)... creature with ,scissor hand-like, claws in fossil records and ... star. , The 505 million year old fossil ... is a distant ancestor of lobsters and scorpions, was ... role as Edward Scissorhands - a movie about an ... scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... The use of genome-wide analysis (GWA), where the entirety ... the genomic mutations or variants which can cause health ... However, it can also pose major ethical problems ... Society of Human Genetics (ESHG) published on line today ... Human Genetics ., Many services based on whole genome ...
(Date:5/16/2013)... don,t ponder our pulses outside of the gym. But doctors ... heart health. , Zhenan Bao, a professor of chemical engineering ... dollar bill and no wider than a postage stamp. The ... wrist, is sensitive enough to help doctors detect stiff arteries ... used to continuously track heart health and provide doctors a ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3
... for the annual infectious diseases meeting of the American ... 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ... Place Convention Center in Chicago, Illinois. ... new information on clinical and basic research in infectious ...
... of a natural body chemical may allow doctors to reduce ... of critically ill patients. "Infection is a common and ... ways to improve the outcomes of sick, elderly patients and, ... Heyland, a professor of Medicine at Queen,s, director of the ...
... the U.S. first responder community,s need for documentary standards ... Institute of Standards and Technology (NIST) Law Enforcement Standards ... to first responders as part of a pilot project ... will help OLES gauge whom needs access to standards ...
Cached Biology News:Finding could reduce antibiotic use in critically ill patients 2It's your standard pilot project: NIST to offer documentary standards to first responders 2
... is a tetramethylrhodamine-conjugated jetSI-ENDO (excitation ... 580 nm), the powerful siRNA ... used to determine the transfection ... delivery and trafficking of siRNAs. ...
... TrackerCumulates a score of movement counts, similar ... it.can track up to 6 subjects at once, ... triggered. Test a whole experimental group at ... the activity. Upgradeable for a variety of ...
... OutputCumulates a score of movement counts, similar to ... track up to 6 subjects at once, in ... Can outpt a sync pulse to coordinate ... use animal location and timing information to control ...
... features of Tracker, plus software to note when ... of the arena, and trigger a penaltyThe Spatial ... built around a video camera, frame grabber, and ... fields at once and up to 6 moving ...
Biology Products: